Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Mar 31, 2025 (2 years ago)

Rocuronium Bromide 50 mg per 5mL

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: Leaking/damaged syringes.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Rocuronium Bromide 50 mg per 5mL (10mg per mL), 5mL Single Dose Syringe, Rx only, Leiters Health, 13796 Compark Blvd, Englewood, CO 80112. NDC: 71449-004-11

Affected NDC 71449-0004-11

Compare with the code on your package — it is the most precise check available.

Drug: Rocuronium

Recalling firm
Denver Solutions, LLC DBA Leiters Health
Origin
CO, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0374-2025 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Rocuronium recalls

See all
Class II · Moderate risk

Rocuronium Bromide Injection

cGMP Deviations: Products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-226-10 D-0371-2024
Class II · Moderate risk

rocuronium 50 mg/5 mL

Lack of Assurance of Sterility:Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 72196-6010-1 D-1113-2023
Class II · Moderate risk

rocuronium

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc D-1076-2023
Class II · Moderate risk

rocuronium50 mg/5 mL

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 72196-6010-1 D-0947-2023

Other recalls by Denver Solutions, LLC DBA Leiters Health

All 2025 recalls
Class II · Moderate risk

Glycopyrrolate

Lack of Assurance of Sterility: Leaking/damaged syringes.

Ongoing Sterility / contamination Denver Solutions, LLC DBA Leiters Health NDC 71449-104-11 D-0370-2025